A team of patients, their families, doctors, and their staff can make a difference in gaining control over diabetes, researchers said….
Read More »Diabetes In Control
Letter from the Editor: November Special Edition
Often when we think of cutting edge technology or modern methods of care the private sector tends to get all the attention and it seems that often government agencies only catch up years later. However, when it comes to healthcare innovations, the Veterans Health Administration often leads the pack. This …
Read More »Medicare Plan Finder URGENT
URGENT: Medicare Plan Finder Let your patients know that their Part D Medicare Plan is going to change Jan 1, 2011. The part D plan they are on for 2010 will be changing and they need to go to a pharmacy if they do not have access to a computer …
Read More »New Product: Cycloset
Santarus Announces Launch of Type 2 Diabetes Drug CYCLOSET CYCLOSET is the first and only centrally acting dopamine agonist oral antidiabetic. CYCLOSET is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with Type …
Read More »Sixty Percent of Cardiovascular Patients are Diabetic or Pre-Diabetic
Sixty Percent of Cardiovascular Patients are Diabetic or Pre-Diabetic: The impact of growing obesity levels is pushing Type 2 diabetes into an epidemic. This is a serious problem for healthcare providers due to the cost of treatment, but also for cardiologists who now see diabetes prevention as one of their …
Read More »Anti-Diabetic Actions of Serotonin Uncovered
Anti-Diabetic Actions of Serotonin Uncovered: New findings suggest that serotonin — a brain chemical known to help regulate emotion, mood and sleep — might also have anti-diabetic properties. It provides an explanation for why individuals prescribed certain kinds of anti-psychotic drugs that affect serotonin signaling sometimes have problems with their …
Read More »Santarus Announces Launch of Type 2 Diabetes Drug CYCLOSET®
CYCLOSET is the first in-class and only centrally acting dopamine agonist oral antidiabetic. CYCLOSET is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus both as monotherapy and in …
Read More »Editor’s Note: Paying Now or Later
When Steve and I put this week’s Clinical Mastery Series issue together I kept thinking of the old Fram oil filter commercials: the ones where the mechanic came on and said, “You can pay me now or pay me later,” referring to the relatively small cost of replacing an oil …
Read More »NCPS: Taking Aim at Medication Errors, Question 4
SF: Can you give an example of how the error reporting works? KT: I have attached a NCPS Alert (in pdf format) from March 2009 on U 500 Insulin. This was the specific incident: “South West VA CMOP received an order for 40 units of U-500 insulin and questioned its …
Read More »NCPS: Taking Aim at Medication Errors, Question 3
SF: What are the most common errors that occur at the VA in regards to diabetes patients and what has the VA done to prevent them from happening again? KT: The data found within NCPS SPOT data is voluntarily reported so it is not a good indicator for prevalence of …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.